Our Pricing

What Happens in Your First Week of Mounjaro Treatment

Starting your first week of Mounjaro treatment in the UK can feel daunting, but understanding what to expect helps ensure a smoother experience. At Cured Pharmacy, our UK-registered clinical team has guided thousands of patients through their initial Mounjaro journey, and this guide draws on that collective expertise to prepare you for week one. All Mounjaro prescriptions require clinical assessment by a UK prescriber before treatment can begin.

Your Starting Dose: The 2.5mg Foundation Phase

Every patient beginning Mounjaro in the UK starts with the 2.5mg dose, regardless of their weight loss goals or medical history [1]. This isn't a therapeutic dose designed to produce significant weight loss—it's a tolerance-building phase that allows your body to adapt to tirzepatide's dual GIP/GLP-1 receptor activity.

The MHRA-approved titration schedule mandates four weeks at 2.5mg before any dose increase [1]. During your first week, you'll administer one subcutaneous injection, typically on the same day each week. Most patients choose a consistent injection day (such as Sunday evening) to establish routine and maintain steady medication levels.

Clinical trials show that starting with this gradual approach significantly reduces the incidence of severe gastrointestinal side effects compared to higher initial doses [2]. Your UK prescriber will provide detailed injection technique guidance, but the KwikPen design makes self-administration straightforward even for injection-naive patients.

Injection Site Selection and Technique

During your first week of Mounjaro treatment, you'll inject into the subcutaneous tissue of your abdomen, thigh, or upper arm. The abdomen (avoiding a 5cm radius around the navel) typically offers the most consistent absorption and is the preferred site for most patients. Rotate injection sites weekly to prevent lipohypertrophy—localised fat accumulation that can impair medication absorption.

Common Side Effects in Week One: What Our Patients Report

In the SURPASS clinical trial programme, approximately 70-80% of patients experienced some gastrointestinal effects during the initial weeks, though most were mild to moderate in severity [1][2]. At Cured Pharmacy, we've observed that realistic expectations significantly improve treatment adherence.

The most frequently reported side effects during the first week of Mounjaro treatment include mild nausea (affecting roughly 30-40% of patients), reduced appetite, occasional bloating, and changes in bowel habits. These effects typically peak 24-72 hours after your first injection and gradually diminish as your body adapts to tirzepatide's effects on gastric emptying.

Severe side effects are uncommon at the 2.5mg starting dose, but you should contact your prescriber immediately if you experience persistent vomiting, severe abdominal pain, signs of pancreatitis, or allergic reactions. Most patients find that eating smaller, more frequent meals and avoiding high-fat foods during week one substantially reduces gastrointestinal discomfort.

Managing Nausea: Practical Strategies from UK Prescribers

If you experience nausea during your first week, eat bland, protein-rich foods in smaller portions throughout the day rather than three large meals. Cold foods are often better tolerated than hot meals, and ginger tea or peppermint can provide natural relief. Avoid lying down immediately after eating, and stay well-hydrated with small, frequent sips of water rather than large volumes at once.

Appetite Changes and Early Weight Loss Expectations

Many patients notice reduced appetite within 24-48 hours of their first Mounjaro injection, though this varies considerably between individuals. Tirzepatide works by activating GLP-1 and GIP receptors in the brain's appetite regulation centres, creating earlier satiety signals and reducing food cravings [3].

During your first week at the 2.5mg dose, weight loss is typically modest—most patients lose 0.5-1.5kg, with much of this attributable to reduced food intake and water weight rather than significant fat loss. Clinical trial data shows that substantial weight reduction occurs progressively over months, not days [1]. The SURPASS-1 trial demonstrated average weight loss of 1.9kg at four weeks on 2.5mg, increasing to 22.5% total body weight reduction over 72 weeks at the maximum 15mg maintenance dose.

It's crucial to maintain realistic expectations during week one. Mounjaro is not a rapid-fix solution but a long-term treatment that works best when combined with dietary modifications and increased physical activity. Your UK prescriber will discuss sustainable lifestyle changes that complement tirzepatide's pharmacological effects.

First Week of Mounjaro Treatment: Practical Daily Considerations

Plan your first injection for a day when you can rest if needed—many patients schedule it for Friday evening or Saturday morning to accommodate potential side effects without work disruption. Keep a symptom diary during week one, noting injection time, meals, side effects, and their severity. This information proves invaluable for your prescriber when assessing your response and planning dose escalation.

Hydration becomes particularly important during your first week, as reduced appetite may inadvertently decrease fluid intake. Aim for 2-2.5 litres of water daily, adjusting for activity level and climate. Dehydration can exacerbate nausea and constipation, two common early side effects.

Avoid alcohol during your first week of Mounjaro treatment, as it can intensify nausea and gastrointestinal effects. Alcohol also impairs blood sugar regulation, which is particularly relevant if you have type 2 diabetes or prediabetes. Your prescriber will advise on safe alcohol consumption once you've established tolerance to the medication.

Medication Interactions and Timing Considerations

Mounjaro slows gastric emptying, which can affect the absorption of oral medications, particularly those requiring rapid onset like pain relief or antibiotics [4]. If you take other prescription medications, discuss timing with your UK prescriber. Generally, taking oral medications at least one hour before or four hours after your Mounjaro injection minimises interaction risk, though individual guidance is essential.

When to Contact Your Prescriber During Week One

While most patients tolerate the 2.5mg starting dose well, certain symptoms warrant immediate medical attention. Contact your UK prescriber or seek emergency care if you experience severe, persistent abdominal pain (particularly if radiating to your back), persistent vomiting preventing fluid intake, signs of allergic reaction (rash, swelling, difficulty breathing), or symptoms of acute pancreatitis.

For patients with type 2 diabetes, monitor blood glucose levels more frequently during your first week, as tirzepatide can cause significant reductions in blood sugar [1]. If you're taking other glucose-lowering medications, your prescriber may have adjusted doses before starting Mounjaro, but hypoglycaemia remains a risk requiring vigilance.

Less urgent but still important: contact your prescriber if nausea persists beyond 72 hours without improvement, if you're unable to maintain adequate nutrition or hydration, or if you have concerns about injection technique. At Cured Pharmacy, our clinical team remains available to support patients throughout their treatment journey, and early intervention often prevents minor issues from becoming treatment barriers.

Comparing Your First Week Experience: Mounjaro vs Other GLP-1 Treatments

Patients switching from semaglutide-based treatments like Wegovy or Saxenda often report that Mounjaro's first week feels similar in terms of appetite suppression but with potentially milder gastrointestinal effects at equivalent efficacy levels [3]. This may relate to tirzepatide's dual receptor activity, which produces weight loss through complementary pathways rather than relying solely on GLP-1 stimulation.

Unlike Saxenda, which requires daily injections, Mounjaro's once-weekly administration means you experience the injection process only once during week one. This convenience factor significantly improves long-term adherence rates, as demonstrated in patient preference studies [4].

The starting dose of 2.5mg Mounjaro produces comparable early appetite effects to Wegovy's 0.25mg starting dose, but the titration schedules differ. Mounjaro escalates more gradually over 20 weeks to reach maximum dose, whilst Wegovy reaches its maintenance dose in 16-20 weeks. Your UK prescriber will recommend the treatment best suited to your medical history, weight loss goals, and tolerance profile. From £135.00 at Cured Pharmacy, Mounjaro represents competitive UK pricing for this advanced dual-agonist therapy.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6
3. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.